Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease [NA]

View source ↗

Summary

This ClinicalTrials.gov update reports on a completed study assessing whether cognitive impairment persists after cure of Cushing's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Cushing's Disease | NA | Status: COMPLETED